Partner Fund Management »

Ascendis Pharma A S shares owned by Partner Fund Management

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by Partner Fund Management from 13F filings

Historical chart of Partner Fund Management investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by Partner Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by Partner Fund Management

Quarter filed Position value Share count Share price at filing
2023-03-31 $22M 202k 107.22
2018-12-31 $1.7M 28k 62.65

More positions owned by Partner Fund Management

Eli Lilly & Co. (LLY)
Cytokinetics Com New (CYTK)
Merck & Co (MRK)
Abbvie (ABBV)
Vertex Pharmaceuticals Incorporated (VRTX)
Humana (HUM)
Edwards Lifesciences (EW)
Becton, Dickinson and (BDX)
McKesson Corporation (MCK)
Tenet Healthcare Corp Com New (THC)
Centene Corporation (CNC)
Karuna Therapeutics Ord
Legend Biotech Corp Sponsored Ads (LEGN)
Penumbra (PEN)
Axsome Therapeutics (AXSM)

View all positions for Partner Fund Management

Top funds holding Ascendis Pharma A S

RA Capital Management
Artisan Partners Limited Partnership
Westfield Capital Management Company
Henderson Group
venBio Select Advisor
Wellington Management Company
Massachusetts Financial Services
T. Rowe Price Associates
Franklin Resources
TimesSquare Capital Management
Alliancebernstein
Brown Advisory Holdings Incorporated
Goldman Sachs Group
Deutsche Bank Aktiengesellschaft
Paradigm Biocapital Advisors

View all funds holding Ascendis Pharma A S